
Sinopia Biosciences wins NCI grant to advance LEADS® oncology platform.
Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced it has been awarded a…












